- $8.40bn
- $8.96bn
- $4.77bn
- 94
- 51
- 99
- 96
Annual income statement for Genpact, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,709 | 4,022 | 4,371 | 4,477 | 4,767 |
| Cost of Revenue | |||||
| Gross Profit | 1,291 | 1,432 | 1,536 | 1,571 | 1,690 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,271 | 3,513 | 3,869 | 3,846 | 4,065 |
| Operating Profit | 439 | 509 | 502 | 631 | 702 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 400 | 483 | 465 | 602 | 677 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 308 | 369 | 353 | 631 | 514 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 308 | 369 | 353 | 631 | 514 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 308 | 369 | 353 | 631 | 514 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.77 | 1.92 | 2.1 | 3.4 | 2.85 |
| Dividends per Share |